Jaykumar Thumar

1.0k total citations
16 papers, 743 citations indexed

About

Jaykumar Thumar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jaykumar Thumar has authored 16 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Jaykumar Thumar's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Treatment and Pharmacology (3 papers) and Renal cell carcinoma treatment (2 papers). Jaykumar Thumar is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Treatment and Pharmacology (3 papers) and Renal cell carcinoma treatment (2 papers). Jaykumar Thumar collaborates with scholars based in United States, Switzerland and Canada. Jaykumar Thumar's co-authors include Howard S. Höchster, Jill Lacy, Harriet M. Kluger, Katherine A. Guthrie, E. Gabriela Chiorean, Stacey Stein, Xiaopan Yao, Rakesh Gaur, Krishna S. Gunturu and Tara Elisabeth Seery and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Molecular Cancer.

In The Last Decade

Jaykumar Thumar

15 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaykumar Thumar United States 10 480 233 189 158 147 16 743
Agata Sasor Sweden 16 543 1.1× 423 1.8× 262 1.4× 121 0.8× 163 1.1× 33 946
Tessa Y. S. Le Large Netherlands 15 407 0.8× 226 1.0× 210 1.1× 57 0.4× 116 0.8× 28 656
János Fillinger Hungary 15 427 0.9× 283 1.2× 119 0.6× 57 0.4× 212 1.4× 46 701
Tuomas Kaprio Finland 14 475 1.0× 268 1.2× 161 0.9× 180 1.1× 127 0.9× 39 782
Yunzhen Qian China 9 471 1.0× 255 1.1× 219 1.2× 79 0.5× 124 0.8× 17 661
Sundhar Ramalingam United States 12 287 0.6× 296 1.3× 81 0.4× 100 0.6× 199 1.4× 25 684
Mareyuki Endoh Japan 18 187 0.4× 306 1.3× 158 0.8× 99 0.6× 195 1.3× 33 786
Emanuela Balladore Italy 8 405 0.8× 272 1.2× 132 0.7× 173 1.1× 67 0.5× 14 771
Chang‐Jun Tan China 14 180 0.4× 224 1.0× 168 0.9× 57 0.4× 99 0.7× 28 706
Masayuki Otsuka Japan 15 300 0.6× 343 1.5× 114 0.6× 109 0.7× 121 0.8× 73 847

Countries citing papers authored by Jaykumar Thumar

Since Specialization
Citations

This map shows the geographic impact of Jaykumar Thumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaykumar Thumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaykumar Thumar more than expected).

Fields of papers citing papers by Jaykumar Thumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaykumar Thumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaykumar Thumar. The network helps show where Jaykumar Thumar may publish in the future.

Co-authorship network of co-authors of Jaykumar Thumar

This figure shows the co-authorship network connecting the top 25 collaborators of Jaykumar Thumar. A scholar is included among the top collaborators of Jaykumar Thumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaykumar Thumar. Jaykumar Thumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Roeland, Eric, Mohamedtaki Abdulaziz Tejani, Eric Cheung, et al.. (2025). A phase 1b dose escalation study of AV-380 (anti-GDF15 monoclonal antibody) in combination with standard-of-care therapy in cancer patients with cachexia.. Journal of Clinical Oncology. 43(16_suppl).
2.
Shroff, Rachna T., Katherine A. Guthrie, Aaron J. Scott, et al.. (2023). SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.. Journal of Clinical Oncology. 41(4_suppl). 57 indexed citations
3.
Cecchini, Michael, Joseph Chao, Yu Shyr, et al.. (2022). Abstract CT170: A phase 1/2 study of olaparib in combination with ramucirumab in metastatic gastric and gastroesophageal junction adenocarcinoma (GEJ). Cancer Research. 82(12_Supplement). CT170–CT170. 1 indexed citations
4.
Ristau, Benjamin T., et al.. (2020). Amyloid Deposition of the Bilateral Ureters in a Patient With Chronic Systemic AL Amyloidosis. Urology. 146. e10–e11. 1 indexed citations
5.
Thumar, Jaykumar, et al.. (2019). Antiphospholipid Syndrome Presenting With Splenic Infarct. JCR Journal of Clinical Rheumatology. 27(1). e19–e19. 2 indexed citations
6.
Cecchini, Michael, Jeremy Kortmansky, Jill Lacy, et al.. (2019). A phase I study of TAS-102 in combination with oxaliplatin (TAS-OX) for refractory metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 37(4_suppl). 630–630. 5 indexed citations
7.
Ramanathan, Ramesh K., Shannon McDonough, Philip A. Philip, et al.. (2019). Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313. Journal of Clinical Oncology. 37(13). 1062–1069. 241 indexed citations
8.
9.
Thumar, Jaykumar, David Shahbazian, Saadia A. Aziz, Lucia B. Jilaveanu, & Harriet M. Kluger. (2014). MEK targeting in N-RAS mutated metastatic melanoma. Molecular Cancer. 13(1). 45–45. 56 indexed citations
10.
Gunturu, Krishna S., Xiaopan Yao, Xiangyu Cong, et al.. (2012). FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity. Medical Oncology. 30(1). 361–361. 115 indexed citations
11.
Gunturu, Krishna S., Jaykumar Thumar, Howard S. Höchster, et al.. (2012). Single institution experience with FOLFIRINOX in advanced pancreatic cancer (PC).. Journal of Clinical Oncology. 30(15_suppl). e14534–e14534. 9 indexed citations
12.
Gunturu, Krishna S., Jaykumar Thumar, Howard S. Höchster, et al.. (2012). Single-institution experience with FOLFIRINOX in advanced pancreatic cancer (PC).. Journal of Clinical Oncology. 30(4_suppl). 330–330. 7 indexed citations
13.
Deshpande, Hari A., Sanziana A. Roman, Jaykumar Thumar, & Julie Ann Sosa. (2011). Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer. Clinical Medicine Insights Oncology. 5. 213–21. 29 indexed citations
14.
Thumar, Jaykumar & Harriet M. Kluger. (2010). Ipilimumab: a promising immunotherapy for melanoma.. PubMed. 24(14). 1280–8. 25 indexed citations
15.
Bagnato, Carolina, Jaykumar Thumar, Viveka Mayya, et al.. (2007). Proteomics Analysis of Human Coronary Atherosclerotic Plaque. Molecular & Cellular Proteomics. 6(6). 1088–1102. 126 indexed citations
16.
Thumar, Jaykumar, Armann Andaya, Anne‐Claude Gingras, et al.. (2006). Identification of Putative Androgen Receptor Interaction Protein Modules. Molecular & Cellular Proteomics. 6(2). 252–271. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agata Sasor Breakdown of academic impact, for papers by Tessa Y. S. Le Large Breakdown of academic impact, for papers by János Fillinger Breakdown of academic impact, for papers by Tuomas Kaprio Breakdown of academic impact, for papers by Yunzhen Qian Breakdown of academic impact, for papers by Sundhar Ramalingam Breakdown of academic impact, for papers by Mareyuki Endoh Breakdown of academic impact, for papers by Emanuela Balladore Breakdown of academic impact, for papers by Chang‐Jun Tan Breakdown of academic impact, for papers by Masayuki Otsuka
Rankless by CCL
2026